Skip to main content

Landos Biopharma, Inc.

LABPDelisted May 23, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001785345

Landos Biopharma, Inc. was delisted on May 23, 2024; its insiders filed their last Form 4 on May 23, 2024; 16 institutions reported holding it in 13F filings for Q1 2024, worth $34.9M in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding Landos Biopharma, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of LABP: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders4733−14
Shares23.3M22.7M−539.9K (−2.3%)
Value$218.9M$261.4M+$42.6M (+19.4%)

New holders (1)

Institutions that held Landos Biopharma, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to LABP in Q2 2021
InstitutionSharesValue% of portfolio
Carroll Financial Associates, Inc.50$00.00%

Sold out (15)

Institutions that held Landos Biopharma, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.